Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;3(3):257-60.
doi: 10.3980/j.issn.2222-3959.2010.03.18. Epub 2010 Sep 18.

Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis

Yi Shao  1 , Yao Yu, Chong-Gang Pei, Ye-Hui Tan, Qiong Zhou, Jing-Lin Yi, Gui-Ping Gao
Affiliations

Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis

Yi Shao et al. Int J Ophthalmol. 2010.

Abstract

Aim: To evaluate the therapeutic efficacy of intracameral amphotericin B (ICAMB) injection in the treatment of keratomycosis.

Methods: The study design was a prospective controlled clinical trial. A total of 60 eyes of 60 patients were divided into two groups, 30 in the ICAMB injection group (group A) and 30 in the control group-topical application amphotericin B (group B). Serial measurements of the size of the keratomycosis-namely, two maximum linear dimensions perpendicular to each other, and the area and perimeter was done at start of therapy and follow up on day 3, 7, and 21. Rate of healing of the keratomycosis were measured as percentage decrease from the baseline parameter at each subsequent follow up. The data were analyzed by the non-parametric Wilcoxon rank sum test.

Results: The mean time to disappearance of hypopyon was 9.6±9.2 (range:1-26) days in group A and 26.8±20.8 (range:14-62) days in group B (P=0.03). The median percentage decrease in the size of the keratomycosis was significantly greater than that in the cord serum group at day 21(P<0.05) when measured in terms of the area and perimeter. A greater number of patients showed complete re-epithelialization in group A (n=27) than in group B (n=14) (P<0.05). None of the patients reported any side effects or discomfort with either treatment.

Conclusion: ICAMB injection leads to faster healing of the keratomycosis refractory to all medical management and reducing time to disapperence of hypopyon compared to topical application amphotericin B.

Keywords: amphotericin B; intracameral injection; keratomycosis; management.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Eyes showing complete re-epithelialization
Figure 2
Figure 2. Healing of epithelial defect
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pleyer U, Grammer J, Pleyer JH, Kosmidis P, Friess D, Schmidt KH, Thiel HJ. Amphotericin B-bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B. Ophthalmologe. 1995;92(4):469–475. - PubMed
    1. Abad JC, Foster CS. Fungal keratitis. Int Ophthalmol Clin. 1996;36(1):1–15. - PubMed
    1. Hirose H, Terasaki H, Awaya S, Yasuma T. Treatment of fungal corneal ulcers with amphotericin B ointment. Am J Ophthalmol. 1997;124(6):836–838. - PubMed
    1. Isipradit S. Efficacy of fluconazole subconjunctival injection as adjunctive therapy for severe recalcitrant fungal corneal ulcer. J Med Assoc Thai. 2008;91(3):309–315. - PubMed
    1. Garcia-Valenzuela E, Song CD. Intracorneal injection of amphothericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol. 2005;123(12):1721–1723. - PubMed

LinkOut - more resources